Keeps Biopharma Inc. (KOSDAQ:256940)

Keeps Biopharma Revenue

Keeps Biopharma had revenue of 43.34B KRW in the quarter ending June 30, 2025, with 37.56% growth. This brings the company's revenue in the last twelve months to 148.36B, up 25.18% year-over-year. In the year 2024, Keeps Biopharma had annual revenue of 127.58B with 38.48% growth.

• Revenue (ttm): 148.36B
• Revenue Growth: +25.18%
• P/S Ratio: 1.39
• Revenue / Employee: 5.30B
• Employees: 28
• Market Cap: 205.60B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	127.58B	35.45B	38.48%
Dec 31, 2023	92.13B	77.52B	530.30%
Dec 31, 2022	14.62B	10.36B	243.08%
Dec 31, 2021	4.26B	-10.96B	-72.00%
Dec 31, 2020	15.22B	1.03B	7.23%